NO992705L - 3-pyridylenantiomere og deres anvendelse som analgetika - Google Patents
3-pyridylenantiomere og deres anvendelse som analgetikaInfo
- Publication number
- NO992705L NO992705L NO992705A NO992705A NO992705L NO 992705 L NO992705 L NO 992705L NO 992705 A NO992705 A NO 992705A NO 992705 A NO992705 A NO 992705A NO 992705 L NO992705 L NO 992705L
- Authority
- NO
- Norway
- Prior art keywords
- analgesics
- pyridylene
- enantiomers
- formula
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3232196P | 1996-12-10 | 1996-12-10 | |
US76327896A | 1996-12-10 | 1996-12-10 | |
PCT/US1997/022811 WO1998025920A1 (en) | 1996-12-10 | 1997-12-10 | 3-pyridyl enantiomers and their use as analgesics |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992705D0 NO992705D0 (no) | 1999-06-03 |
NO992705L true NO992705L (no) | 1999-08-03 |
Family
ID=26708255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992705A NO992705L (no) | 1996-12-10 | 1999-06-03 | 3-pyridylenantiomere og deres anvendelse som analgetika |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0950057B1 (no) |
JP (2) | JP4272261B2 (no) |
KR (2) | KR100472154B1 (no) |
CN (1) | CN1125064C (no) |
AT (1) | ATE227717T1 (no) |
AU (1) | AU733881B2 (no) |
BG (1) | BG64196B1 (no) |
BR (1) | BR9714677A (no) |
CA (2) | CA2273917C (no) |
DE (1) | DE69717148T2 (no) |
DK (1) | DK0950057T3 (no) |
ES (1) | ES2189003T3 (no) |
HU (1) | HUP0001110A3 (no) |
IL (1) | IL130083A0 (no) |
NO (1) | NO992705L (no) |
NZ (1) | NZ335810A (no) |
PL (1) | PL333920A1 (no) |
PT (1) | PT950057E (no) |
SK (1) | SK75999A3 (no) |
TR (1) | TR199901904T2 (no) |
WO (1) | WO1998025920A1 (no) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA00009619A (es) | 1998-04-02 | 2006-03-09 | Targacept Inc | Composiciones farmaceuticas y metodos de uso. |
US6054451A (en) * | 1998-04-21 | 2000-04-25 | Algos Pharmaceutical Corporation | Analgesic composition and method for alleviating pain |
US6541669B1 (en) | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
US20010031771A1 (en) | 1999-05-24 | 2001-10-18 | Gary Maurice Dull | Pharmaceutical compositions and methods for use |
US6103911A (en) * | 1999-06-15 | 2000-08-15 | Abbott Laboratories | Process for reduction of (2R)-4-oxoazetidinone-2-carboxylic acid |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
CA2485466A1 (en) * | 2002-05-15 | 2003-11-27 | Abbott Laboratories | Treatment of neuropathic pain |
EP1741709A1 (en) | 2005-06-28 | 2007-01-10 | Sanofi-Aventis Deutschland GmbH | Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
ATE448230T1 (de) | 2005-12-09 | 2009-11-15 | Hoffmann La Roche | Für die behandlung von obesitas geeignete tricyclische amidderivate |
TW200800020A (en) * | 2006-01-26 | 2008-01-01 | Basf Ag | Methods to use 3-pyridyl derivatives as pesticides |
EP2083921A2 (en) | 2006-09-04 | 2009-08-05 | Neurosearch A/S | Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer |
JP4939192B2 (ja) * | 2006-12-05 | 2012-05-23 | ユニ・チャーム株式会社 | 不織布、不織布の製造方法及び吸収性物品 |
DE102007058504A1 (de) | 2007-12-05 | 2009-07-09 | Acino Ag | Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR) |
WO2010045212A2 (en) | 2008-10-14 | 2010-04-22 | Psychogenics, Incstatuts | Nicotinic acetylcholine receptor ligands and the uses thereof |
AR075988A1 (es) * | 2009-04-09 | 2011-05-11 | Lilly Co Eli | Compuesto de piridiloxi - pirrolidina inhibidor de recaptacion de serotonina y norepinefrina, composicion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de dolor cronico |
US8474529B2 (en) * | 2009-04-09 | 2013-07-02 | Regency Technologies Llc | Control of concentric tubing direction |
CN103619354A (zh) | 2011-06-30 | 2014-03-05 | 东丽株式会社 | 止痒剂 |
WO2014160783A1 (en) | 2013-03-27 | 2014-10-02 | Georgetown University | 2-halo-5-alkynyl-pyridyl nicotinic ligands |
CA3066361A1 (en) | 2017-06-07 | 2018-12-13 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US11511103B2 (en) | 2017-11-13 | 2022-11-29 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
WO2019152875A1 (en) | 2018-02-01 | 2019-08-08 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
JP2022540616A (ja) | 2019-07-12 | 2022-09-16 | シファメド・ホールディングス・エルエルシー | 血管内血液ポンプならびに製造および使用の方法 |
WO2021016372A1 (en) | 2019-07-22 | 2021-01-28 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
WO2021062265A1 (en) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
WO2021062270A1 (en) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Catheter blood pumps and collapsible pump housings |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8301702D0 (en) * | 1983-01-21 | 1983-02-23 | Shell Int Research | Azetidine compounds |
US4902684A (en) * | 1988-06-20 | 1990-02-20 | E. R. Squibb & Sons, Inc. | Benzazepine and benzothiazepine derivatives |
US5068234A (en) * | 1990-02-26 | 1991-11-26 | Sterling Drug Inc. | 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles |
IL107184A (en) * | 1992-10-09 | 1997-08-14 | Abbott Lab | Heterocyclic ether compounds that enhance cognitive function |
US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
IL118279A (en) * | 1995-06-07 | 2006-10-05 | Abbott Lab | Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission |
US5629325A (en) * | 1996-06-06 | 1997-05-13 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
-
1997
- 1997-12-10 PL PL97333920A patent/PL333920A1/xx unknown
- 1997-12-10 CA CA2273917A patent/CA2273917C/en not_active Expired - Fee Related
- 1997-12-10 WO PCT/US1997/022811 patent/WO1998025920A1/en not_active Application Discontinuation
- 1997-12-10 EP EP97952392A patent/EP0950057B1/en not_active Expired - Lifetime
- 1997-12-10 NZ NZ335810A patent/NZ335810A/en unknown
- 1997-12-10 CA CA2698384A patent/CA2698384C/en not_active Expired - Fee Related
- 1997-12-10 BR BR9714677-3A patent/BR9714677A/pt not_active IP Right Cessation
- 1997-12-10 DK DK97952392T patent/DK0950057T3/da active
- 1997-12-10 CN CN97181628A patent/CN1125064C/zh not_active Expired - Fee Related
- 1997-12-10 PT PT97952392T patent/PT950057E/pt unknown
- 1997-12-10 HU HU0001110A patent/HUP0001110A3/hu unknown
- 1997-12-10 TR TR1999/01904T patent/TR199901904T2/xx unknown
- 1997-12-10 JP JP52698398A patent/JP4272261B2/ja not_active Expired - Fee Related
- 1997-12-10 SK SK759-99A patent/SK75999A3/sk unknown
- 1997-12-10 DE DE69717148T patent/DE69717148T2/de not_active Expired - Lifetime
- 1997-12-10 ES ES97952392T patent/ES2189003T3/es not_active Expired - Lifetime
- 1997-12-10 AT AT97952392T patent/ATE227717T1/de active
- 1997-12-10 IL IL13008397A patent/IL130083A0/xx unknown
- 1997-12-10 AU AU56010/98A patent/AU733881B2/en not_active Ceased
- 1997-12-10 KR KR10-2003-7008788A patent/KR100472154B1/ko not_active IP Right Cessation
- 1997-12-10 KR KR10-1999-7005151A patent/KR100422995B1/ko not_active IP Right Cessation
-
1999
- 1999-06-03 NO NO992705A patent/NO992705L/no not_active Application Discontinuation
- 1999-07-06 BG BG103556A patent/BG64196B1/bg unknown
-
2008
- 2008-12-24 JP JP2008327771A patent/JP5364872B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0950057T3 (da) | 3-pyridylenantiomerer og deres anvendelse som analgetika | |
BRPI0408784A (pt) | método para usar um composto | |
NO20060971L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
EA200000723A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
DK1137762T3 (da) | Behandling af Pompes sygdom | |
SE9604786D0 (sv) | New compounds | |
BR0212252A (pt) | Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero | |
ES2157957T3 (es) | Procedimientos para inhibir la endometriosis. | |
DK0998287T3 (da) | Anvendelse af levobupivacain | |
MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
DK0723444T3 (da) | Levobupivacain, som er egnet til behandling af kronisk smerte | |
NO990433L (no) | Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet | |
DE60045508D1 (de) | Dalda-analoge und ihre verwendung | |
UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
GT199900015A (es) | Procedimiento para tratar la insuficiencia cardiaca | |
BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
PT1039900E (pt) | Agentes terapeuticos | |
BR9506552A (pt) | Método de inibição de integrase retroviral | |
GR3025568T3 (en) | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia. | |
DK0986393T3 (da) | Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer | |
NO991734L (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
DE69813681D1 (de) | Neue triazole als therapeutische mittel gegen pilzinfektionen | |
SE9802538D0 (sv) | New pharmaceutically active compounds | |
LV11524A (lv) | Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |